Website of the Department of Health
Please note that this website has a UK government access keys system.
Page menu
Home
- Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection (ARHAI)
- Advisory Committee on Clinical Excellence Awards (ACCEA)
- Advisory Committee on Dangerous Pathogens (ACDP)
- Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO)
- Advisory Group on Hepatitis (AGH)
- Committee on the Medical Effects of Air Pollutants (COMEAP)
- Expert Advisory Group on AIDS (EAGA)
- Genetics and Insurance Committee (GAIC)
- Gene Therapy Advisory Committee (GTAC)
- Joint Committee on Vaccination and Immunisation (JCVI)
- Ministerial Medical Technology Strategy Group (MMTSG)
- National Blood Transfusion Committee (NBTC)
- National Clinical Audit Advisory Group (NCAAG)
- National Expert Panel on New and Emerging Infections (NEPNEI)
- Patient Information Advisory Group (PIAG)
- Scientific Pandemic Influenza Advisory Committee (SPI)
- Scientific Committee on Tobacco and Health (SCOTH)
- Standing Commission on Carers (SCOC)
- UK Stem Cell Initiative (UKSCI)
- Archive
- Advanced search
- Search results
- Help
- RSS Library
- Terms and conditions
- Site map
You are here:
Gene Therapy Advisory Committee (GTAC)
The Gene Therapy Advisory Committee (GTAC) has UK-wide responsibility for the ethical oversight of proposals to conduct clinical trials involving gene or stem cell therapies. The Committee also advises Ministers on the development and use of gene and stem cell therapies and works with other Government agencies with an interest in this area, such as the Medicines and Healthcare products Regulatory Agency (MHRA), the Health and Safety Executive (HSE) and the Human Tissue Authority (HTA).
What’s new?
16 December 2009
15 December 2009
GTAC has worked with the Department of Health, along with other regulators of stem cell research, to develop an on-line resource for researchers called the UK stem cell tool kit. The website allows stem cell researchers to build a customised map outlining all of the regulatory steps to take their ideas for a new treatment from the laboratory to patients. Researchers are asked seven key regulatory questions. Depending on their answers, a unique regulatory route map is generated on-screen, indicating all of the regulatory requirements and points of contact within the relevant organisations to help the researchers take their projects forward. The tool kit can be accessed at:
Additional links
Related links
Help viewing PDFs
Useful tips to ensure you get the most from PDFs and the free Reader program. Topics covered include accessibility, troubleshooting and searching files.
Global links
Access keys
- Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection (ARHAI)
- Scientific Committee on Tobacco and Health (SCOTH)
- Joint Committee on Vaccination and Immunisation (JCVI)
- Advisory Committee on Dangerous Pathogens (ACDP)
- Advisory Committee on Clinical Excellence Awards (ACCEA)
- Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection (ARHAI)
